Effect of Thymoquinone Extracted From Nigella Sativa in the Treatment of Arsenical Keratosis
NCT04686461 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2021-01-08
Summary
Prepare an ointment from Nigella sativa seeds extract and apply it over palmer arsenical keratosis patient for 12 weeks. After than the effect of the ointment will be observed by measuring the keratotic nodular size before and after the intervention.
Conditions
- Keratotic Nodular Size
Interventions
- DRUG
-
Nigella sativa seeds extract containing ointment intervention
Nigella sativa seeds extract containing ointment Nigella sativa seed extract, bee wax, white petrolatum, stearyl alcohol
Sponsors & Collaborators
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
lead OTHER
Principal Investigators
-
Bangladesh Bhanga, Faridpur · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-20
- Primary Completion
- 2021-01-20
- Completion
- 2021-02-20
Countries
- Bangladesh
Study Locations
More Related Trials
-
Photodynamic Treatment of Actinic Keratoses With Different Light Doses
NCT01541228 ·Status: COMPLETED ·Phase: NA
-
Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis
NCT03632733 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses
NCT01481155 ·Status: UNKNOWN ·Phase: NA
-
Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin
NCT03006185 ·Status: COMPLETED ·Phase: PHASE2
-
Electrocautery vs Q-switch for Seborrheic Keratosis
NCT02366559 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
NCT02990221 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
NCT00894647 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
NCT01459393 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
NCT01656226 ·Status: UNKNOWN ·Phase: PHASE4
-
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
NCT00814528 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
NCT00189267 ·Status: COMPLETED ·Phase: PHASE2
-
LAS41005 in Hyperkeratotic Actinic Keratosis
NCT01358851 ·Status: COMPLETED ·Phase: PHASE2
-
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
NCT00756288 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis
NCT00991861 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
NCT01516515 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Nicotinamide Treatments for Actinic Keratosis
NCT07049068 ·Status: COMPLETED ·Phase: PHASE1
-
Fractional CO2 Laser Assisted Photodynamic Therapy
NCT01260987 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris
NCT04797663 ·Status: COMPLETED ·Phase: PHASE4
-
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
NCT03642535 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
The Real Life Topical Field Treatment of Actinic Keratosis Study
NCT02362152 ·Status: COMPLETED
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
NCT00605176 ·Status: COMPLETED ·Phase: PHASE3
-
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
NCT04842422 ·Status: COMPLETED ·Phase: PHASE4